TSVT

2seventy bio
TSVT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

TSVT was delisted on the 13th of May, 2025.

Back to rankings
 

About: 2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Employees: 65

Healthcare Biotechnology
Price charts implemented using Lightweight Charts™